Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Notice of Intent to Sole Source for Takeda Group's Gammagard by the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. The response date is November 16, 2026, and the contract is active as of November 13, 2026.
Scope Of Work: The NIH Clinical Center intends to negotiate with Takeda Pharmaceutical Company Limited for the procurement of Gammagard S/D 10gm and 5gm kits. The Pharmacy department requires 10 bottles of each kit to meet the ongoing patient care needs for those enrolled in clinical trials. This acquisition is crucial for maintaining consistent treatment for multiple patients currently on therapy with Gammagard S/D.
Qualification Criterion: This is a sole source procurement as Takeda Group is the only responsible source for Gammagard S/D. The NIH requires these specific items to ensure consistent treatment for patients, as Gammagard S/D is included in the Clinical Center’s formulary. No other suppliers can meet the unique needs for these pharmaceuticals.
Purchaser contact is for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Warwick Turnpike Improvements | USA | 152563791 | 24 Nov 2026 |
| Miscellaneous Services Cftc Headquarters | USA | 152555589 | 13 Dec 2026 |
| Fy27 Aashto Accreditation and Inspection Services | USA | 152555587 | 27 Nov 2026 |
| Capitol Perimeter Enhancements Cpe Designbuild Construction Project | USA | 152555555 | 04 Dec 2026 |
| Designbuild Designbidbuild Multipleaward Taskorder Contract in Lithuania and Latvia | USA | 152555547 | 12 Dec 2026 |